We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection.
- Authors
Miyakawa, Kei; Kubo, Sousuke; Jeremiah, Sundararaj Stanleyraj; Go, Hirofumi; Yamaoka, Yutaro; Ohtake, Norihisa; Kato, Hideaki; Ikeda, Satoshi; Mihara, Takahiro; Matsuba, Ikuro; Sanno, Naoko; Miyakawa, Masaaki; Shinkai, Masaharu; Miyazaki, Tomoyuki; Ogura, Takashi; Ito, Shuichi; Kaneko, Takeshi; Yamamoto, Kouji; Goto, Atsushi; Ryo, Akihide
- Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits varying degrees of protective immunity conferred by neutralizing antibodies (nAbs). In this study, we report the persistence of nAb responses over 12 months after infection despite their decreasing trend noticed from 6 months. Methods The study included sera from 497 individuals who had been infected with SARS-CoV-2 between January and August 2020. Samples were collected at 6 and 12 months after onset. The titers of immunoglobulin (Ig)G to the viral nucleocapsid protein (NP) and receptor-binding domain (RBD) of the spike protein were measured by chemiluminescence enzyme immunoassay. The nAb titer was determined using lentivirus-based pseudovirus or authentic virus. Results Antibody titers of NP-IgG, RBD-IgG, and nAbs were higher in severe and moderate cases than in mild cases at 12 months after onset. Although the nAb levels were likely to confer adequate protection against wild-type viral infection, the neutralization activity to recently circulating variants in some of the mild cases (~30%) was undermined, implying the susceptibility to reinfection with the variants of concerns (VOCs). Conclusions Coronavirus disease 2019 convalescent individuals have robust humoral immunity even at 12 months after infection albeit that the medical history and background of patients could affect the function and dynamics of antibody response to the VOCs.
- Subjects
CORONAVIRUS diseases; COVID-19; HUMORAL immunity; COVID-19 pandemic; VIRUS diseases; ANTIBODY titer
- Publication
Open Forum Infectious Diseases, 2022, Vol 9, Issue 2, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofab626